2025. Abemaciclib in real clinical practice of adjuvant therapy of HR+/HER2- high-risk breast cancer: experience of centers in Moscow. Voprosy onkologii. 71, 3 (Jun. 2025), OF-2319. DOI:https://doi.org/10.37469/0507-3758-2025-71-3-OF-2319.